search icon
      blog search icon

      ACRV Stock Price History and Quote Analysis: Insights for Investors

      Acrivon Therapeutics, Inc.

      (NASDAQ:ACRV)

      $3.88

      0.06 (1.57%)

      At Close: 4:00 PM

      ACRV Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      ACRV Stock Price Today

      Acrivon Therapeutics, Inc. (ACRV) stock rallied over 1.57% intraday to trade at $3.88 a share on NASDAQ. The stock opened with a gain of 41.36% at $5.40 and touched an intraday high of $5.40, rising 1.57% against the last close of $3.82. The Acrivon Therapeutics, Inc. in stock market went to a low of $4.96 during the session.

      ACRV Stock Snapshot

      $3.82

      Prev. Close

      85.75 Million

      Market Cap

      $4.96

      Day Low

      $5.40

      Open

      N/A

      Number of Shares

      $5.40

      Day High

      N/A

      P/E ratio

      -2.30

      EPS (TTM)

      6.40

      Cash Flow per Share

      N/A

      Free Float in %

      6.25

      Book Value

      21573.00

      Volume

      ACRV Stock Price History Chart

      DateOpenHighLowCloseVolume

      Contact Details

      480 Arsenal Way
      Suite 100
      Watertown, MA 02472
      United States

      Website:https://www.acrivon.com

      Contact #:617 207 8979

      Company Information

      EmployeesN/A

      Beta0.88

      Sales or RevenueN/A

      5Y Sales Change0.00%

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryBiotechnology

      About Company

      Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in a potentially registrational Phase 2 trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response and cell cycle regulation pathways, such as WEE1, a protein kinase and PKMYT1, a protein serine/threonine kinase. The company was incorporated in 2018 and is based in Watertown, Massachusetts.

      Peers

      Frequently Asked Questions

      icon

      What is the current Acrivon Therapeutics, Inc. (ACRV) stock price?

      Acrivon Therapeutics, Inc. (NASDAQ: ACRV) stock price is $3.88 in the last trading session. During the trading session, ACRV stock reached the peak price of $5.40 while $4.96 was the lowest point it dropped to. The percentage change in ACRV stock occurred in the recent session was 1.57% while the dollar amount for the price change in ACRV stock was $0.06.

      icon

      ACRV's industry and sector of operation?

      The NASDAQ listed ACRV is part of Biotechnology industry that operates in the broader Healthcare sector. Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform.

      icon

      Who are the executives of ACRV?

      Ms. Katharine Peterson CPA
      Vice President of Fin. & Accounting
      Ms. Kristina Masson M.B.A., Ph.D.
      Co-Founder, Executive Vice President of Bus. Operations, Treasurer, Sec. & Director
      Dr. Peter Blume-Jensen M.D., Ph.D.
      Co-Founder, Chairman, Chief Executive Officer, Pres & Acting Chief Scientific Officer
      Mr. Joon Jung Ph.D.
      Vice President & Head of Data Science

      icon

      How ACRV did perform over past 52-week?

      ACRV's closing price is 0.40% higher than its 52-week low of $4.9605 where as its distance from 52-week high of $25.47 is -0.56%.

      icon

      How many employees does ACRV have?

      Number of ACRV employees currently stands at N/A. ACRV operates from 480 Arsenal Way<br/>Suite 100<br/>Watertown, MA 02472<br/>United States.

      icon

      Link for ACRV official website?

      Official Website of ACRV is: https://www.acrivon.com

      icon

      How do I contact ACRV?

      ACRV could be contacted at phone #617 207 8979 and can also be accessed through its website. ACRV operates from 480 Arsenal Way<br/>Suite 100<br/>Watertown, MA 02472<br/>United States.

      icon

      How many shares of ACRV are traded daily?

      ACRV stock volume for the day was 21573.00 shares. The average number of ACRV shares traded daily for last 3 months was 19.41 Thousands.

      icon

      What is the market cap of ACRV currently?

      The market value of ACRV currently stands at $85.75 Million with its latest stock price at $3.88 and N/A of its shares outstanding.